PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsanaphylaxis
MeSH D000707 - anaphylaxis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D006969:Immediate hypersensitivity
0 Companies
0 Drugs
Success rate
D000707: 
Anaphylaxis
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
3MEpinephrine Medihaler-epi  1982-01-01   
Abbott BiotherapeuticsLidocaine, Epinephrine Lidocaine W/ Epinephrine  1982-01-01   
Promethazine Promethazine  1982-01-01   
Able LaboratoriesPromethazine Promethazine  2003-02-27   
Adamis PharmaceuticalsEpinephrine Symjepi 2036-10-20 2017-06-15   
AllerganLidocaine, Epinephrine Lidocaine W/ Epinephrine  1982-01-01   
Promethazine Prometh  1982-01-01   
Promethazine Promethazine  2003-06-24   
Codeine, Promethazine Promethazine Codeine  1984-10-31   
AlpharmaPromethazine Prometh Fortis  1982-01-01   
AltanaPromethazine Zipan  1982-01-01   
American RegentEpinephrine Epinephrine  2018-07-06   
Promethazine Promethazine  2003-03-19   
Amneal PharmaceuticalsPromethazine Promethazine  2009-12-30   
Codeine, Promethazine Promethazine Codeine  2013-04-24   
Dextromethorphan, Promethazine Promethazine Dextromethorphan  2011-02-08   
Phenylephrine, Codeine, Promethazine Promethazine Hydrochloride,phenylephrine W/codeine  2015-08-26   
Phenylephrine, Promethazine Promethazine Phenylephrine  2009-08-25   
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
33%
1/3
Phase 2
33%
1/3
Phase 3
100%
3/3
Approved: 3Overall Success rate: 11%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use